Kodiak Sciences Inc. (KOD:NASDAQ) soared at $73.41, representing a gain of 49.2%. On Tue 03 Dec 19, KOD:NASDAQ touched a New 2-Week Intraday High of $60.72. The stock got featured on our News Catalysts scanner on Wed 04 Dec 19 at 05:02 AM in the 'PUBLIC OFFERING' category. From Tue 12 Nov 19, the stock recorded 64.29% Up Days and 66.67% Green Days
The stock spiked on Mon 02 Dec 19 at $72.87 with a volume of 5M+.
About Kodiak Sciences Inc. (KOD:NASDAQ)
Kodiak Sciences Inc is a clinical stage company. It is engaged in developing innovative therapeutics to treat high prevalence of ophthalmic diseases.
Top 10 Gainers:
- Protagonist Therapeutics, Inc. (PTGX:NASDAQ), 72.92%
- iBio, Inc. (IBIO:NYSEMKT), 51.06%
- Kodiak Sciences Inc. (KOD:NASDAQ), 49.21%
- Allakos Inc. (ALLK:NASDAQ), 43.56%
- Jason Industries, Inc. (JASN:NASDAQ), 41.44%
- Anavex Life Sciences Corp. (AVXL:NASDAQ), 28.39%
- Comstock Mining Inc. (LODE:NYSEMKT), 27.71%
- Obsidian Energy Ltd. (OBE:NYSE), 22.55%
- Applied Therapeutics, Inc. (APLT:NASDAQ), 21.7%
- Neurotrope, Inc. (NTRP:NASDAQ), 21.3%